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linical Course of Atrial Ectopic
achycardia Is Age-Dependent: Results and
reatment in Children 3 or 3 Years of Age
ack C. Salerno, MD, Naomi J. Kertesz, MD, FACC, Richard A. Friedman, MD, FACC,
rnold L. Fenrich, JR, MD, FACC
ouston, Texas
OBJECTIVES We assessed the clinical presentation, natural history, and treatment response of atrial ectopic
tachycardia (AET) in children 3 years of age (group 1) compared with those 3 years of
age (group 2).
BACKGROUND Atrial ectopic tachycardia is a common cause of chronic supraventricular tachycardia in
children and can be resistant to pharmacologic therapy. Radiofrequency ablation (RFA) can
eliminate AET arising from a single focus.
METHODS A retrospective review identified all children at Texas Children’s Hospital diagnosed with
AET from March 1991 to November 2000. Data obtained included clinical presentation,
echocardiographic evaluation, response to antiarrhythmic therapy, spontaneous resolution,
and outcomes of radiofrequency and surgical ablation.
RESULTS Sixty-eight children were identified (22 children 3 years and 46 children 3 years of age).
Control of AET with antiarrhythmic therapy was achieved in 91% of the younger children
but only 37% of the older children (p  0.001). There was a higher rate of spontaneous
resolution in the younger group (78%) compared with the older group (16%) (p  0.001).
Radiofrequency ablation was performed in 35 of the older children, with ultimate success in
74%. Surgical intervention was required for six children.
CONCLUSIONS Younger children respond to antiarrhythmic therapy and have a high incidence of AET
resolution, thus warranting a trial of antiarrhythmic therapy. In children 3 years, AET is
unlikely to resolve spontaneously, and antiarrhythmic medications are frequently ineffective.
Thus, RFA should be considered early in the course of treatment for these children; however,
surgical intervention may be necessary. (J Am Coll Cardiol 2004;43:438–44) © 2004 by
the American College of Cardiology FoundationS
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strial ectopic tachycardia (AET) is a common cause of
hronic supraventricular tachycardia (SVT) in children (1)
nd is thought to be due to rapid discharges from an
utomatic atrial focus distinct from the sinus node. Histor-
cally, AET has been resistant to pharmacologic therapy
2–4). More recently, limited treatment success has been
eported with class Ic and class III antiarrhythmics (5–7).
he natural history of AET includes possible progression to
ongestive heart failure (2,4), and it represents one of the
ew reversible etiologies of cardiomyopathy (4,8,9). Radio-
requency ablation (RFA) of SVT in children has been
uccessful with a low risk of significant complications
10,11), and there is a high short-term success rate for AET
rising from a single focus (11,12). To date, studies report-
ng the clinical course of AET have been limited by small
umbers. The purpose of our study was to determine if the
linical course of AET, with regard to infants and older
hildren, was similar to that of accessory-pathway-mediated
From the Lillie Frank Abercrombie Section of Pediatric Cardiology, Texas
hildren’s Hospital, Baylor College of Medicine, Houston, Texas.
Manuscript received April 6, 2003; revised manuscript received August 20, 2003,occepted September 8, 2003.VT with a bimodal distribution characterized by the
ossibility of early disappearance with late recurrence (13).
ETHODS
retrospective review of the pediatric cardiology database
t Texas Children’s Hospital identified all children who
ere diagnosed with AET during the RFA era from March
991 to November 2000. Atrial ectopic tachycardia is
haracterized electrophysiologically such that: 1) the P wave
f the first beat is identical to that of subsequent beats; 2)
he cycle length of the first few beats progressively shorten;
) atrioventricular block can occur in the presence of
ontinuing SVT; and 4) tachycardia typically cannot be
nduced or terminated with standard pacing protocols
14,15). Inclusion in the study was based upon either
lectrocardiogram (ECG) or 24-h Holter findings that met
stablished criteria for AET detailed above. Patients were
xcluded if they had ECG appearance of multifocal atrial
achycardia at presentation or more than one mechanism for
achycardia. Data obtained included patient demographics,
linical presentation, echocardiographic evaluation, re-
ponse to antiarrhythmic therapy, occurrence of spontane-
us resolution, and outcomes of RFA and surgical ablation.
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February 4, 2004:438–44 Clinical Course of Atrial Ectopic Tachycardiaased on evidence that younger children may have a
ifferent response to medication as well as a higher rate of
esolution, three years of age was chosen to divide the
atient population into two groups. Additionally, our policy
as been to use three years as the cutoff for RFA. This takes
nto account the pediatric radiofrequency registry data and
he higher risks of complications in children 15 kg (16).
ecause 15 kg is the 50th percentile for a three-year-old and
typical three-year-old would be of sufficient size to reduce
he risks of RFA, this age cutoff has been used for many
ears. In our study, group 1 includes all children who
resented with AET at 3 years of age, whereas group 2
ncludes all children who presented with AET at 3 years
f age.
efinitions. Although determination of objective mea-
ures of ventricular function were complicated by the un-
erlying arrhythmia, a cardiomyopathy was defined as a
hortening fraction 28% or an ejection fraction 40%
Simpson’s biplane method). Control of AET during ther-
py was defined as either normal sinus rhythm, or rate
ontrol of AET with normal heart rate variability on a 24-h
olter. Resolution was defined as normal sinus rhythm on
24-h Holter after antiarrhythmic therapy was discontin-
ed for at least one month with no recurrence of symptoms.
hen discussing coexistent heart disease, the presence of a
atent ductus arteriosus was not included as an anatomic
bnormality if evident only on the first postnatal echocar-
iogram performed at less than one month of age.
lectrophysiology procedure. Each patient was studied in
he fasting state. All antiarrhythmic medications were dis-
ontinued a minimum of five half lives before the study. In
he majority of cases, conventional mapping was performed
sing standard electrode and ablation catheters with bipolar
lectrograms displayed on a computerized system (Cardio-
ab, Prucka Engineering, Sugar Land, Texas). At the end of
he study period, three-dimensional electroanatomic map-
ing using the CARTO system (Biosense-Webster, Dia-
ond Bar, California) became available at our institution.
tatistics. Baseline comparisons between the age groups
ere performed using a two-tailed Fisher exact test for
ategorical variables and a two sample t test for numerical
alues. After baseline comparisons were performed, the
ariables that were found to differ between groups were then
ncluded in a multiple logistic regression analysis in order to
ontrol for their effects. Age was analyzed as both a
Abbreviations and Acronyms
AET atrial ectopic tachycardia
ECG electrocardiogram/electrocardiographic/
electrocardiography
LA  left atrial/atrium
RA  right atrial/atrium
RFA  radiofrequency ablation
SVT  supraventricular tachycardiarouping variable and in terms of years. pESULTS
roup 1. PATIENT PROFILE. There were 22 patients diag-
osed with AET at 3 years of age (median, 7 days; range,
day to 2 years). The mean follow up time was 25 months
range, 2 to 180 months). There were two patients in the
ounger group who were lost to follow-up. Five patients
ho were diagnosed with SVT in utero met electrophysi-
logic criteria for AET postnatally and were included with
heir diagnosis made at one day of age.
RESENTATION. Common reasons for referral in the
ounger group included an irregular heart rate (10 patients),
achycardia (6 patients), feeding difficulties (2 patients), and
or other reasons (4 patients). At presentation, echocardio-
rams were performed in 20 of 22 (91%). There was
chocardiographic evidence of decreased ventricular func-
ion in three patients. Most of these patients with decreased
unction had shortening fractions ranging from 20% to 27%;
owever, a severe cardiomyopathy (ejection fraction by
impson’s biplane method of 18%) resulting in referral for
ransplant evaluation was seen in a single patient. Addition-
lly, there were five anatomic abnormalities detected by
chocardiography. The abnormalities included a perimem-
ranous ventricular septal defect in three patients, and a
ecundum atrial septal defect in two patients. None of these
atients with septal defects have required surgical interven-
ion, with four of the five defects having closed spontane-
usly. The fifth patient is currently being treated with
iuretic therapy for mild pulmonary overcirculation.
NTIARRHYTHMIC THERAPY. Antiarrhythmic medications
ere used as the initial therapy in all 22 of the younger
atients, with a median of three drugs (range, 1 to 5) per
atient. Drug doses were typically increased to achieve
linical control or until measured serum levels were thera-
able 1. Medical Management in Children 3 Years of Age
n  22)
Drug
Treatment
Regimens Control Ineffective
3 2 1
B 4 3 1
 BB 12 3 9
 BB  Flec 2 1 1
 BB  Amio 1 1
B  Flec 1 1
 Sot 5 1 4
 Sot  Flec 4 2 2
 Amio 2 1 1
 Amio  Flec 4 2 2
lec 3 2* 1
 Flec 3 2 1
mio 1 1
otal 45 21* 24
A single patient was initially placed on, and controlled with, flecainide, but due to
oxic side effects was changed to digoxin and propranolol with continued control.
Amio  amiodarone; BB  beta-blocker; D  digoxin; Flec  flecainide; Sot 
otalol.eutic. Control of AET while on antiarrhythmic therapy
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Clinical Course of Atrial Ectopic Tachycardia February 4, 2004:438–44as achieved in 20 of 22 (91%). Drugs used in the younger
roup and their effects are detailed in Table 1. Most patients
n the younger group (17 of 22) received digoxin and/or a
eta-blocker as the first line of medical therapy. Additional
rst line medications in the younger patients included
ecainide (3 patients), amiodarone (1 patient), and a com-
ination of digoxin and sotalol (1 patient). Responders to
rst line therapy included eight of the 17 who were treated
ith digoxin and/or a beta-blocker, as well as two of the
hree who were on flecainide. The patients started on sotalol
r amiodarone as first line therapy did not achieve control
ntil additional medications were added.
Drug toxicity occurred in two patients in the younger
roup. One child who was receiving flecainide developed a
ew right bundle branch block with an accelerated ventric-
lar rhythm, and a second child had a toxic flecainide level
flecainide level 1,700 ng/dl on 120 mg/m2/day) without
vidence of clinical toxicity.
PONTANEOUS RESOLUTION. Excluding four patients in
he younger group who were still on drug therapy, 14 of the
ossible 18 (78%) patients had complete resolution. The
ean duration of therapy in those patients whose AET did
pontaneously resolve was 12  7 months.
FA. Only two of the 22 patients in the younger group who
ere diagnosed at less than three years of age underwent
FA; both were successful in the short term. Their ages at
he time of RFA were six months and nine years. The
ix-month-old underwent RFA due to a progressive cardio-
yopathy despite medical therapy with amiodarone. The
blation was successful with an early recurrence of AET.
he AET focus was modified by the RFA as it was more
asily controlled with medication after ablation, followed by
esolution once antiarrhythmics were discontinued. The
lder of these two patients had been on multiple antiar-
hythmic combinations and ultimately underwent a success-
ul RFA secondary to family preference.
URGICAL INTERVENTION. None of the patients in the
ounger group required surgical intervention.
ARDIOMYOPATHY. All three of the patients who presented
ith myocardial dysfunction in the younger group had
mproved function after intervention. The two patients who
resented with mild-to-moderate myocardial dysfunction
oth had improved function while on antiarrhythmic ther-
py. The single patient in the younger group with a severe
ardiomyopathy was discussed above. He was tried on
ultiple medical regimens without success and ultimately
nderwent RFA at six months of age. Due to recurrence of
ET after RFA, he was placed on, and responded to,
miodarone with normalization of function.
roup 2. PATIENT PROFILE. There were 46 patients diag-
osed with AET at 3 years of age (median, 10 years;
ange, 3 to 18 years). The mean follow-up time was 20
onths (range, 1 week to 120 months). There were threeatients in the older group who were lost to follow-up. RESENTATION. Common reasons for referral included ir-
egular heart rate (16 patients), tachycardia (13 patients),
alpitations (11 patients), and for other reasons (6 patients).
t presentation, echocardiograms were performed in 40 of
6 (87%) in the older group. There was echocardiographic
vidence of decreased function in eight patients with a
evere cardiomyopathy resulting in referral for transplant
valuation in two patients (ejection fractions by Simpson’s
iplane method of 16% and 20%). The single anatomic
bnormality in the older group consisted of a quadricuspid
ortic valve that was neither stenotic nor regurgitant.
NTIARRHYTHMIC THERAPY. Antiarrhythmic medications
ere used as the initial therapy in 35 of 46 (76%) of the
lder patients, with a median of two drugs (range, 1 to 5)
er patient. Similar to the younger group, drug doses were
ypically increased to achieve clinical control or until mea-
ured serum levels were therapeutic. Control of AET while
n antiarrhythmic therapy was achieved in only 13 of 35
37%) of the older children. Drugs used in the older group
nd their effects are detailed in Table 2. As with the younger
roup, most patients (30 of 35) in the older group were
nitially started on digoxin and/or beta-blocker therapy.
dditional first line medications included procainamide (1
atient), ethmozine (1 patient), flecainide (1 patient), and a
ombination of digoxin and quinidine (2 patients). There
ere 13 patients in the older group who achieved control,
ine of whom received digoxin and/or beta-blocker therapy.
dditional medications used to achieve control in the older
roup included ethmozine (1 patient), flecainide with a beta
locker (1 patient), and digoxin with flecainide (2 patients).
here were no toxic side effects in the older group.
PONTANEOUS RESOLUTION. Excluding four patients who
ere still on therapy, only five of the possible 31 (16%)
atients in the older group had complete resolution. The
ean duration of therapy in those patients whose AET did
pontaneously resolve was similar to the younger group at 12
able 2. Medical Management in Children 3 Years of Age
n  35)
Drug
Treatment
Regimens Control Ineffective
16 3 13
B 5 2 3
 BB 13 4 9
lec 3 3
rocainamide 1 1
 Sot 3 3
 Sot  Flec 2 2
 Flec 5 2 3
thmozine 1 1
 Quinidine 2 2
erapamil 1 1
B  Flec 1 1
 Ethmozine 1 1
otal 54 13 41
bbreviations as in Table 1.7 months. The children in the older group who did not
h
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February 4, 2004:438–44 Clinical Course of Atrial Ectopic Tachycardiaave resolution of their AET and ultimately underwent
FA received an average of 33  2 months of antiarrhyth-
ic therapy before RFA.
FA. In total, 39 patients from the older group underwent
n electrophysiology study; however, in six of these patients,
heir AET was either suppressed secondary to sedation or
uiescent preventing mapping of the focus during the study.
ltimately, RFA was performed in 35 patients in the older
roup, including two patients who had no AET during the
nitial attempt in the electrophysiology laboratory. Indica-
ions for RFA in the older group included tachycardia
espite antiarrhythmic therapy (17 patients), patient choice
16 patients), and cardiomyopathy (6 patients). As depicted
n Figure 1, RFA was successful in the short term in 30 of
5 (86%). There were 10 patients who had recurrence of
Figure 1. Outcome after radiofrequency ablation (RFA).
igure 2. Location of ectopic foci and outcome of radiofrequency lesions.
VC  inferior vena cava; LAA  left atrial appendage; RAA  rightstrial appendage; SVC  superior vena cava.ET after RFA. Successful repeat ablations were achieved
n four of those who had recurrence and in two of the initial
ailures, giving ultimate success in 26 of 35 (74%) in the
lder group. Figure 2 details the location of successful
blations, the recurrences, and the failures. The ectopic
ocus was left-sided in 22 of 35 patients, of which 12 were
n the left atrial (LA) appendage, nine near the entry of the
ulmonary veins, and one on the free wall of left atrium
LA). The remainder (13 of 35) of the foci were right-sided
ith six in the right atrial (RA) appendage, four on the free
all of the right atrium (RA), and three at the margin of the
uperior vena cava and RA appendage. As demonstrated in
igure 3, most patients (70%) who had a recurrence after
blation did so in the first three months after ablation. Six
f the recurrences were located in an atrial appendage, three
n the RA appendage, and three in the LA appendage. The
emainder of the recurrences were located near the right
pper pulmonary veins (3 patients), and one on the free wall
f the LA. Of the five failures, there were two in the RA
ppendage, one in the LA appendage, and two at the
unction of the RA and RA appendage. Although six
ecurrences and three failures were located in an atrial
ppendage, there was not statistical significance between
ocation of the focus and outcome of ablation. In the 10
atients with recurrence after RFA (Fig. 3), additional
herapy included successful repeat RFA in four patients,
uccessful surgical appendectomy in three patients, and
uccessful medical therapy in three patients (1 was lost to
ollow-up after successful medical therapy).
Overall, there were 44 RFAs performed with three
omplications: 1) a thrombus on the anterior leaflet of the
itral valve without sequelae after a precautionary six-week
ourse of coumadin; 2) the RFA catheter adhered to the
trial appendage requiring manual removal of the ablation
atheter, with termination of the procedure; 3) an intramu-
al hematoma of the pulmonary vein with echocardio-
raphic resolution and no evidence of pulmonary vein
tenosis after therapy with aspirin.
Due to concerns of performing RFA in young children,
here were only three patients in our study who were three
ears of age or younger at the time of their RFA. The
oungest patient was described above, having undergone
FA at six months of age and a weight of 7 kg. The two
ther children, both from the older group, underwent RFA
t three years of age, weighing 14 and 17 kg, respectively.
ne of these patients had a successful RFA; the other
equired surgical appendectomy after recurrence. There
ere no complications in these three children.
URGICAL INTERVENTION. Whereas none of the patients in
he younger group required surgical intervention, six pa-
ients in the older group required surgery after first under-
oing an attempt at RFA; one patient for failure of the first
FA, two for failure after the second RFA, and three for
ecurrence after ablation. One of the patients required a
econd surgical intervention after an RA appendectomy, due
t
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Clinical Course of Atrial Ectopic Tachycardia February 4, 2004:438–44o recurrence at the margin of the RA appendage. There-
ore, a total of seven surgical interventions were performed
ith three cryoablations and four atrial appendectomies.
ltimately, there was success in all six patients who under-
ent a surgical procedure at latest follow-up. There were no
omplications after surgery.
ARDIOMYOPATHY. All eight of the patients in the older
roup who presented with myocardial dysfunction had
mproved function after intervention. There were six pa-
ients with mild-to-moderate myocardial dysfunction; of
hese, three had improved function after surgical therapy,
wo after successful RFA, and one with antiarrhythmic
herapy. One of the two patients in the older group who
resented with a severe cardiomyopathy had RFA of a focus
n the high RA with resolution of the AET and subsequent
ormalization of function. The second patient had RFA of
n LA focus with early recurrence due to the emergence of
second LA focus requiring a second catheterization and
FA one week later. The second RFA resulted in a
eduction, but not termination, of the rate of AET focus.
inus rhythm was achieved with the initiation of amioda-
one after ablation. Ventricular function had begun to
ormalize after the second RFA and subsequently normal-
zed completely after treatment with amiodarone. While
ttempting to wean the amiodarone several years later, there
as recurrence of AET, and, thus, the patient had a third
FA that was successful in eliminating the focus com-
letely.
ISCUSSION
edical therapy. Control of AET while on antiarrhyth-
ic therapy (Table 3) was achieved in 20 of 22 (91%) of the
ounger children in our study and only 13 of 35 (37%) of the
Figure 3. Outcome after recurrence following radioflder children (p  0.001). Additionally, there was a higherrequency of spontaneous resolution of AET in the younger
roup with 14 of the possible 18 (78%) having complete
esolution, compared with only five out of the possible 31
16%) in the older group (p  0.001). After controlling for
he baseline effects that differed between groups (Table 4),
ge in years was still predictive of both control on antiar-
hythmic therapy (p  0.02) and resolution (p  0 .04).
tatistical control included variables that may only indicate
nherent age effects and not differences in disease state, in
hich case statistical control may represent overadjustment.
n spite of this, when these factors were adjusted, the effect
f age persisted.
ncy ablation (RFA). NSR  normal sinus rhythm.
able 3. Summary of Clinical Course
Group 1
(n  22)
Group 2
(n  46)
ge at presentation (median) 7 days 10 yrs
chocardiography
Decreased ventricular function 3 8
Cardiomyopathy 1 2
ntiarrhythmic medications
Initial therapy 22 (100%) 35 (76%)
Agents per patient (median) 3 2
Control of AET achieved 20 (91%)* 13 (37%)*
Drug toxicity 2 0
pontaneous resolution 14/18 (78%)* 5/31 (16%)*
Duration of treatment (mean) 12 mo 12 mo
adiofrequency ablation
Number of patients 2 35
Immediate success 2 (100%) 30 (86%)
Recurrence 1 10
urgical intervention 0 6
Immediate success 6
Recurrence 1
ollow-up (mean) 25 mo 20 mo
ost to follow-up 2 3
Statistically significant (p  0.05).
AET  atrial ectopic tachycardia.
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February 4, 2004:438–44 Clinical Course of Atrial Ectopic TachycardiaThe results of our study are consistent with the findings of
ehta et al. (5), von Bernuth et al. (6), and Bauersfeld et al.
17) who also found a high incidence of resolution of AET
fter withdrawal of antiarrhythmic therapy, particularly if
iagnosed early in life. Spontaneous resolution of AET after
uccessful pharmacologic control has been reported to be 72%
n infants 6 months of age and 30% in older children as
ompiled from eight contemporary studies by Saul et al. (18).
nlike the findings of Koike et al. (4), who reported resolution
f AET in several older patients, we found spontaneous
esolution in our older patient population to be distinctly rare.
hus, our study confirms that response to medical therapy and
pontaneous resolution is age-dependent.
A standard approach to drug therapy for AET remains
roblematic; however, our results show that control of AET
hile on antiarrhythmic therapy was achieved in 20 of 22
91%) of the younger children and only 13 of 35 (37%) of
he older children (p  0.001). Therefore, drug therapy
hould be considered as the primary therapeutic modality,
articularly in younger children. Although there is a large
ariability in the choice of medications, digoxin and beta
lockers remain our first-line medications followed by
ecainide. Although several authors have reported success
ith amiodarone (6,7), we tend to reserve amiodarone as a
econd-line medication due to possible side effects and its
ong half life, which makes it difficult to discontinue and/or
hange to a new antiarrhythmic medication if amiodarone is
neffective. In our experience, amiodarone has had some
eneficial effect as an additional agent and has primarily
een used for the younger children due to their higher
hance of resolution and a defined end point of therapy.
As this was a retrospective study, all children who met
riteria for the diagnosis of AET were included, which
esulted in enrollment in the study of several children who
ad nonsustained and nonincessant episodes of AET. Our
tudy includes seven patients in the younger group and three
atients in the older group who had nonsustained and
onincessant episodes of AET. All seven of the patients in
he younger group responded to medication with six con-
inuing on to resolution of AET after withdrawal of
ntiarrhythmic therapy. In the older group, all three patients
able 4. Pretreatment Variables
Group 1
(n  22)
Group 2
(n  46) p Value
ge at diagnosis (median) 7 days 10 yrs
ender
Male 13 (59%) 26 (57%)
Female 9 (41%) 20 (43%) p  0.97
ymptoms at diagnosis* 5 (23%) 29 (63%) p  0.001
aximal rate of tachycardia
(mean)*
243 158 p  0.001
chocardiography
Decreased ventricular
function
3 (14%) 8 (17%) p  0.90
Statistically significant difference.ith nonsustained AET responded to medication, with two yurrently on antiarrhythmic therapy and one having resolu-
ion of AET. If these patients were excluded from the study,
he number of responders to medication (p  0.05) and the
ikelihood of resolution (p  0.05) would remain statisti-
ally significant between the two groups.
Due to the difference in resolution and response to
ntiarrhythmic therapy, one might speculate that there may
e a different underlying substrate for AET in younger
hildren versus older children. The younger children may
ave a focus of abnormal cells with more rapid phase 4
epolarization that either involutes or degenerates with time
esulting in resolution. The older children, on the other
and, might have a focus that has become irritated due to
nflammation or scarring such as that from myocarditis.
We did not find any evidence of late recurrence after
pontaneous resolution in our younger patient group. This is
n opposition to reentrant SVT that presents with a bimodal
istribution (13) where younger patients are likely to have
esolution with recurrence at a later age.
It is interesting that the occurrence of AET appears to be
ess common in adults than in children (3,15). It may not be
s rare in adults as previously believed, as there is evidence
hat focal atrial fibrillation in adults results from a focus in
he pulmonary veins (19) or other atrial structures and, thus,
ay be a similar etiology to AET in children. The atrial
yocardium in children may be more stable and, therefore,
ess vulnerable to AET degenerating into atrial fibrillation.
blative therapy. In our study, the ectopic focus was more
ikely to be left-sided; however, both atrial appendages were
common source of the ectopic focus. Although six
ecurrences and three failures were located in an atrial
ppendage, there was no statistical significance between
ocation of the focus and outcome of ablation, possibly due
o the small sample size. A higher recurrence/failure rate in
he atrial appendage may be related to its trabeculated
ature, which makes catheter manipulation and adequate
issue contact difficult. Although there have been reports of
ET due to multiple foci, we encountered multiple foci in
nly a minority of our patient population. As demonstrated
y several patients in our study, AET can be easily sup-
ressed in the catheterization laboratory by sedation, and
herefore, all attempts should be made to minimize sedation
ut ensure patient comfort.
Due to our reluctance to perform RFA in younger
hildren, there was a bias to make every effort to treat the
ounger children with antiarrhythmic agents. For the older
hildren, there appears to be a more favorable risk-to-
enefit ratio with RFA as compared with antiarrhythmic
gents, which have their own inherent risks. Although a
tudy by Blaufox et al. (20) did support the use of RFA by
xperienced physicians in selected infants, it is generally
elieved that a favorable risk-to-benefit ratio may not exist
or the younger children. Additionally, concern regarding
he late enlargement of radiofrequency lesions placed in the
mmature atrial myocardium should be kept in mind with
ounger children (21). We recommend that, before consid-
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hildren medically at least through infancy. However, if they
evelop a cardiomyopathy, we would recommend an elec-
rophysiology study with consideration of RFA or, if nec-
ssary, surgical intervention, especially if the focus is in an
trial appendage, as surgery can be performed without the
eed for cardiopulmonary bypass and with fairly low risk
22).
linical features. In our study, AET was not associated
ith any significant congenital heart defects; however, there
as evidence by echocardiography of decreased myocardial
unction in 11 patients. All of these patients had improved
yocardial function after intervention; therefore, echocar-
iographic assessment at the time of diagnosis is important.
onclusions. In children 3 years of age, AET is unlikely
o resolve spontaneously, and antiarrhythmics are frequently
neffective. As RFA has been used successfully and safely
10,11) in this age group, it should be considered early in the
ourse of treatment, especially if there is an associated
achycardia-induced cardiomyopathy. For children younger
han three years of age, we recommend every effort be made
o establish control of AET with antiarrhythmic agents,
hus allowing for spontaneous resolution of AET or, alter-
atively, delaying RFA until they are older. Although AET
s rarely associated with congenital heart disease, echocar-
iography is important to assess for left ventricular dysfunc-
ion, which may result from chronic tachycardia. In our
xperience, AET is most often left-sided, and the atrial
ppendages are a common focus. Due to the large number
f trabeculations, RFA in an atrial appendage may fail or
ecur, and surgical appendectomy/cryoablation may be
equired.
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